The Role of IT in a Healthy Business Ecosystem: An Exploratory Study of the Korean Capital Market from a Keystone Company\u27s Perspective

The business environmental structure is constantly being shaped by customer\u27s desires and market dynamics. A large number of loosely interconnected participants make up a business ecosystem, and offers a customized and complete set of products and services. In a business ecosystem, the competitiveness of a company is influenced by its own capability and its interrelated partners\u27 capabilities. Therefore, a company should enhance not only its competitiveness but also related companies\u27 capabilities. To do this, a company has to find its place in the business ecosystem to make a complete business strategy using IT. This paper provides business ecosystem strategies and academic guidelines from the perspective of a single company. Firstly, a business ecosystem perspective is conceptualized, and the importance of a keystone company\u27s role in the ecosystem is examined. Then, using a case study method, focus is put on the keystone\u27s IT capabilities that pave the way for a healthy business ecosystem. This paper explores the Korean Capital Market as an example of a business ecosystem and finds the role of IT, particularly from the perspective of a keystone company. Through this study, it is confirmed that the keystone company\u27s IT capabilities play an important role in the healthy business ecosystem. This paper provides guidelines to practitioners in keystone companies and gives ideas to IT researchers

Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney

L-2-hydroxyglutarate (L-2HG) is an oncometabolite found elevated in renal tumors. However, this molecule might have physiological roles that extend beyond its association with cancer, as L-2HG levels are elevated in response to hypoxia and during Drosophila larval development. L-2HG is known to be metabolized by L-2HG dehydrogenase (L2HGDH), and loss of L2HGDH leads to elevated L-2HG levels. Despite L2HGDH being highly expressed in the kidney, its role in renal metabolism has not been explored. Here, we report our findings utilizing a novel CRISPR/Cas9 murine knockout model, with a specific focus on the role of L2HGDH in the kidney. Histologically, L2hgdh knockout kidneys have no demonstrable histologic abnormalities. However, GC-MS metabolomics demonstrates significantly reduced levels of the TCA cycle intermediate succinate in multiple tissues. Isotope labeling studies with [U-13C] glucose demonstrate that restoration of L2HGDH in renal cancer cells (which lowers L-2HG) leads to enhanced incorporation of label into TCA cycle intermediates. Subsequent biochemical studies demonstrate that L-2HG can inhibit the TCA cycle enzyme α-ketoglutarate dehydrogenase. Bioinformatic analysis of mRNA expression data from renal tumors demonstrates that L2HGDH is co-expressed with genes encoding TCA cycle enzymes as well as the gene encoding the transcription factor PGC-1α, which is known to regulate mitochondrial metabolism. Restoration of PGC-1α in renal tumor cells results in increased L2HGDH expression with a concomitant reduction in L-2HG levels. Collectively, our analyses provide new insight into the physiological role of L2HGDH as well as mechanisms that promote L-2HG accumulation in disease states

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Background/AimsThe most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for hepatocellular carcinoma (HCC) patients after LT is still debated.MethodsNinety-three LT recipients with HCC who took tacrolimus and steroids as major immunosuppressants were included. Induction with basiliximab was implemented in 43 patients (46.2%). Mycophenolate mofetil (MMF) was added to reduce the tacrolimus dosage (n=28, 30.1%). The 1-year tacrolimus exposure level was 7.2 ± 1.3 ng/mL (mean ± SD).ResultsThe 1- and 3-year recurrence rates of HCC were 12.9% and 19.4%, respectively. Tacrolimus exposure, cumulative steroid dosages, and MMF dosages had no impact on HCC recurrence. Induction therapy with basiliximab, high alpha fetoprotein (AFP; >400 ng/mL) and protein induced by vitamin K absence/antagonist-II (PIVKA-II; >100 mAU/mL) levels, and microvascular invasion were significant risk factors for 1-year recurrence (P<0.05). High AFP and PIVKA-II levels, and positive 18fluoro-2-deoxy-d-glucose positron-emission tomography findings were significantly associated with 3-year recurrence (P<0.05).ConclusionsInduction therapy with basiliximab, a strong immunosuppressant, may have a negative impact with respect to early HCC recurrence (i.e., within 1 year) in high-risk patients

Cost analysis of depression using the national insurance system in South Korea: a comparison of depression and treatment-resistant depression

The incidence and burden of depressive disorders are increasing in South Korea. There are many differences between pharmaceutically treated depression (PTD) and treatment-resistant depression (TRD), including the economic consequences; however, to our knowledge, the economic burden of depression is understudied in South Korea. Therefore, the objective of the present study was to calculate the different economic costs of PTD and TRD in South Korea, specifically by comparing several aspects of medical care. This study comprised patients aged 18 and over who were newly prescribed antidepressants for more than 28 days with a depression code included from January 1, 2012, to December 31, 2012, by the Health Insurance Review and Assessment Service (HIRA). TRD was classified as more than two antidepressant regimen failures in PTD patients. The cost was calculated based on the cost reflected on the receipt registered with HIRA. Of the 834,694 patients with PTD, 34,812 patients (4.17%) were converted to TRD. The cost of medical care for TRD (6,610,487 KRW, 5881 USD) was approximately 5 times higher than the cost of non-TRD (1,273,045 KRW, 1133 USD) and was significantly higher for patients with or without depression and suicide codes. Medical expenses incurred by non-psychiatrists were roughly 1.7 times higher than those incurred by psychiatrists. TRD patients had significantly higher healthcare costs than PTD patients. Identifying these financial aspects of care for depression can help to establish a more effective policy to reduce the burden on mentally ill patients.This study was funded by the Janssen Korea Ltd. (RRA-17716), and also confirms that Jansen has the author of the study. Two authors (G.J.C. and M.K.2) and the Janssen Korea contributed for conceptualization, investigation, funding acquisition and wrting original draft. However, the funder (Jansen and its employees) had no possibilities to influence the analyses, interpretation of data and and in writing the manuscript

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

Background/AimsThe dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living-donor liver transplantation (LDLT).MethodsTwo sequential studies were performed in adult LDLT between October 2009 and 2011. First, we performed a prospective pharmacokinetic study in 15 recipients. We measured the area under the curve from 0 to 12 hours (AUC0-12) for mycophenolic acid at postoperative days 7 and 14, and we performed a protocol biopsy before discharge. Second, among 215 recipients, we reviewed 74 patients who were initially administered a reduced dose of MMF (1.0 g/day) with tacrolimus (trough, 8-12 ng/mL during the first month, and 5-8 ng/mL thereafter), with a 1-year follow-up. We performed protocol biopsies at 2 weeks and 1 year post-LDLT.ResultsIn the first part of study, AUC0-12 was less than 30 mgh/L in 93.3% of cases. In the second, validating study, 41.9% of the recipients needed dose reduction or cessation due to side effects within the first year after LDLT. At 12 months post-LDLT, 17.6% of the recipients were administered a lower dose of MMF (0.5 g/day), and 16.2% needed permanent cessation due to side effects. The 1- and 12-month rejection-free survival rates were 98.6% and 97.3%, respectively.ConclusionsA reduced dose of MMF was associated with low blood levels compared to the existing recommended therapeutic range. However, reducing the dose of MMF combined with a low level of tacrolimus was feasible clinically, with an excellent short-term outcome in LDLT

The Role of IT in the Relationship between Business Ecosystem\u27s Healthiness and Flagship Firm\u27s Performance: A Conceptual Foundation and Empirical Validation

A business ecosystem\u27s healthiness may be attributed to the superior financial performance of a firm. This paper develops the concept of a business ecosystem\u27s healthiness as an organizational capability and empirically examines the association between healthiness and a firm\u27s financial performance with the moderating effect of IT capability. To do this, a business ecosystem\u27s healthiness is conceptualized by the ecology and business network research stream. Moreover, the relationship between a business ecosystem\u27s healthiness, a flagship firm\u27s performance, and IT capability are examined using the Structured Equation Model. If this study produces expected the results, this paper can be a backgrounder for a business ecosystem\u27s academic guidelines in the perspective of a single compan

Graphitic Porous Carbon Derived from Waste Coffee Sludge for Energy Storage

Coffee is one of the largest agricultural products; however, the majority of the produced coffee is discarded as waste sludge by beverage manufacturers. Herein, we report the use of graphitic porous carbon materials that have been derived from waste coffee sludge for developing an energy storage electrode based on a hydrothermal recycling procedure. Waste coffee sludge is used as a carbonaceous precursor for energy storage due to its greater abundance, lower cost, and easier availability as compared to other carbon resources. The intrinsic fibrous structure of coffee sludge is based on cellulose and demonstrates enhanced ionic and electronic conductivities. The material is primarily composed of cellulose-based materials along with several heteroatoms; therefore, the waste sludge can be easily converted to functionalized carbon. The production of unique graphitic porous carbon by hydrothermal carbonization of coffee sludge is particularly attractive since it addresses waste handling issues, offers a cheaper recycling method, and reduces the requirement for landfills. Our investigations revealed that the graphitic porous carbon electrodes derived from coffee sludge provide a specific capacitance of 140 F g&minus;1, with 97% retention of the charge storage capacity after 1500 cycles at current density of 0.3 A g&minus;1

Microarray Analysis of Rat Pancreas Reveals Altered Expression of Alox15 and Regenerating Islet-Derived Genes in Response to Iron Deficiency and Overload

<div><p>It is well known that iron overload can result in pancreatic iron deposition, beta-cell destruction, and diabetes in humans. Recent studies in animals have extended the link between iron status and pancreatic function by showing that iron depletion confers protection against beta-cell dysfunction and diabetes. The aim of the present study was to identify genes in the pancreas that are differentially expressed in response to iron deficiency or overload. Weanling male Sprague-Dawley rats (n = 6/group) were fed iron-deficient, iron-adequate, or iron-overloaded diets for 3 weeks to alter their iron status. Total RNA was isolated from the pancreases and pooled within each group for microarray analyses in which gene expression levels were compared to those in iron-adequate controls. In iron-deficient pancreas, a total of 66 genes were found to be differentially regulated (10 up, 56 down), whereas in iron-overloaded pancreas, 164 genes were affected (82 up, 82 down). The most up-regulated transcript in iron-deficient pancreas was arachidonate 15-lipoxygenase (Alox15), which has been implicated in the development of diabetes. In iron-overloaded pancreas, the most upregulated transcripts were Reg1a, Reg3a, and Reg3b belonging to the regenerating islet-derived gene (Reg) family. Reg expression has been observed in response to pancreatic stress and is thought to facilitate pancreatic regeneration. Subsequent qRT-PCR validation indicated that Alox15 mRNA levels were 4 times higher in iron-deficient than in iron-adequate pancreas and that Reg1a, Reg3a, and Reg3b mRNA levels were 17–36 times higher in iron-overloaded pancreas. The elevated Alox15 mRNA levels in iron-deficient pancreas were associated with 8-fold higher levels of Alox15 protein as indicated by Western blotting. Overall, these data raise the possibility that Reg expression may serve as a biomarker for iron-related pancreatic stress, and that iron deficiency may adversely affect the risk of developing diabetes through up-regulation of Alox15.</p></div

Top 10 most up-regulated and down-regulated genes in FeO pancreas.

a<p>Fold change log₂ relative to iron-adequate rat pancreas.</p>*<p>In gene ontology category in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0086019#pone-0086019-g001" target="_blank">Figure 1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0086019#pone.0086019.s003" target="_blank">Table S3</a>.</p